279 related articles for article (PubMed ID: 25769687)
1. The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery.
Du H; Liu M; Yang X; Zhai G
Drug Discov Today; 2015 Aug; 20(8):1004-11. PubMed ID: 25769687
[TBL] [Abstract][Full Text] [Related]
2. pH sensitive alginate-chitosan hydrogel beads for carvedilol delivery.
Meng X; Li P; Wei Q; Zhang HX
Pharm Dev Technol; 2011 Feb; 16(1):22-8. PubMed ID: 20028209
[TBL] [Abstract][Full Text] [Related]
3. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
[TBL] [Abstract][Full Text] [Related]
4. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
5. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
Zhang N; Li J; Jiang W; Ren C; Li J; Xin J; Li K
Int J Pharm; 2010 Jun; 393(1-2):212-8. PubMed ID: 20394813
[TBL] [Abstract][Full Text] [Related]
6. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
Bergström CA; Holm R; Jørgensen SA; Andersson SB; Artursson P; Beato S; Borde A; Box K; Brewster M; Dressman J; Feng KI; Halbert G; Kostewicz E; McAllister M; Muenster U; Thinnes J; Taylor R; Mullertz A
Eur J Pharm Sci; 2014 Jun; 57():173-99. PubMed ID: 24215735
[TBL] [Abstract][Full Text] [Related]
7. In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media.
Markopoulos C; Andreas CJ; Vertzoni M; Dressman J; Reppas C
Eur J Pharm Biopharm; 2015 Jun; 93():173-82. PubMed ID: 25836053
[TBL] [Abstract][Full Text] [Related]
8. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
9. Ionotropically cross-linked pH-sensitive IPN hydrogel matrices as potential carriers for intestine-specific oral delivery of protein drugs.
El-Sherbiny IM; Salama A; Sarhan AA
Drug Dev Ind Pharm; 2011 Feb; 37(2):121-30. PubMed ID: 20615156
[TBL] [Abstract][Full Text] [Related]
10. Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application.
Fernandes M; Gonçalves IC; Nardecchia S; Amaral IF; Barbosa MA; Martins MC
Int J Pharm; 2013 Sep; 454(1):116-24. PubMed ID: 23850814
[TBL] [Abstract][Full Text] [Related]
11. Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugs.
Lee SH; Song JG; Han HK
J Control Release; 2019 Oct; 311-312():74-84. PubMed ID: 31487499
[TBL] [Abstract][Full Text] [Related]
12. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
Deng L; Dong H; Dong A; Zhang J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
[TBL] [Abstract][Full Text] [Related]
13. Are chitosan formulations mucoadhesive in the human small intestine? An evaluation based on gamma scintigraphy.
Säkkinen M; Marvola J; Kanerva H; Lindevall K; Ahonen A; Marvola M
Int J Pharm; 2006 Jan; 307(2):285-91. PubMed ID: 16310992
[TBL] [Abstract][Full Text] [Related]
14. Utility of an oxidation reaction for the spectrophotometric determination of acarbose in controlled release tablets at various simulated gastrointestinal media.
Sinha VR; Kumar RV
Acta Pol Pharm; 2012; 69(1):23-32. PubMed ID: 22574503
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in chitosan films for controlled release of drugs.
Mengatto LN; Helbling IM; Luna JA
Recent Pat Drug Deliv Formul; 2012 Aug; 6(2):156-70. PubMed ID: 22436027
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
17. Chitosan coatings to control release and target tissues for therapeutic delivery.
Jennings JA; Wells CM; McGraw GS; Velasquez Pulgarin DA; Whitaker MD; Pruitt RL; Bumgardner JD
Ther Deliv; 2015 Jul; 6(7):855-71. PubMed ID: 26228776
[TBL] [Abstract][Full Text] [Related]
18. Effect of preparation conditions on the nutrient release properties of alginate-whey protein granular microspheres.
Chen L; Subirade M
Eur J Pharm Biopharm; 2007 Mar; 65(3):354-62. PubMed ID: 17150342
[TBL] [Abstract][Full Text] [Related]
19. Development of sensor elements to control drug release from capsular drug delivery systems.
Gröning R; Danco I; Müller RS
Int J Pharm; 2007 Aug; 340(1-2):61-4. PubMed ID: 17462841
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
